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Abstract
Response-adaptive designs have been extensively studied and used
in clinical trials. However, there is a lack of a comprehensive study of
response-adaptive designs that include covariates, despite their impor-
tance in clinical experiments. Because the allocation scheme and the
estimation of parameters are affected by both the responses and the
covariates, covariate-adjusted response-adaptive (CARA) designs are
very complex to formulate. In this paper, we overcome the technical
hurdles and lay out a framework for general CARA designs for the
allocation of subjects to K(≥ 2) treatments. The asymptotic proper-
ties are studied under certain widely satisfied conditions. The proposed
CARA designs can be applied to generalized linear models. Two impor-
tant special cases, the linear model and the logistic regression model,
are considered in detail.
1. Preliminaries.
1.1. Brief history. In most clinical trials, patients accrue sequentially.
Response-adaptive designs provide allocation schemes that assign different
treatments to incoming patients based on the previous observed responses of
patients. A major objective of response-adaptive designs in clinical trials is
to minimize the number of patients that is assigned to the inferior treatment
to a degree that still generates useful statistical inferences. The ethical
and other characteristics of response-adaptive designs have been extensively
discussed by many authors (e.g., Zelen and Wei (1995)).
1Research supported by a grant from the National Natural Science Foundation of China
(No. 10471126).
2Research supported by grants DMS-0204232 and DMS-0349048 from the National
Science Foundation (USA).
3Research supported by a grant from the Research Grants Council of the Hong Kong
Special Administrative Region (Project no. CUHK400204).).
AMS 2000 subject classifications. 60F15, 62G10, 60G10, 60F05.
Key words and phrases. Clinical trial, covariate information, adaptive designs, asymp-
totic normality.
1
Early important work on response-adaptive designs was carried out by
Thompson (1933) and Robbins (1952). Since then, a steady stream of re-
search (Zelen (1969), Wei and Durham (1978), Eisele and Woodroofe (1995))
in this area has generated various treatment allocation schemes for clinical
trials. Some of the advantages of using response-adaptive designs have been
recently studied by Hu and Rosenberger (2003) and Rosenberger and Hu
(2004).
In many clinical trials, covariate information is available that has a strong
influence on the responses of patients. For instance, the efficacy of a hyper-
tensive drug is related to a patient’s initial blood pressure and cholesterol
level, whereas the effectiveness of a cancer treatment may depend on whether
the patient is a smoker or a non-smoker.
The following notations and definitions are introduced to describe the
randomized treatment allocation schemes. Given a clinical trial with K
treatments. Let X1,X2, ... be the sequence of random treatment assign-
ments. For the m-th subject, Xm = (Xm,1, . . . ,Xm,K) represents the as-
signment of treatment such that if the m-th subject is allocated to treat-
ment k, then all elements in Xm are 0 except for the k-th component,
Xm,k, which is 1. Let Nm,k be the number of subjects assigned to treat-
ment k in the first m assignments and write Nm = (Nm,1, . . . , Nm,K). Then
Nm =
∑m
i=1Xi. Suppose that {Ym,k, k = 1, . . . ,K, m = 1, 2 . . .} denote
the responses such that Ym,k is the response of the m-th subject to treat-
ment k, k = 1, . . . ,K. In practical situations, only Ym,k with Xm,k = 1 is
observed. Denote Ym = (Ym,1, . . . , Ym,K). Let Xm = σ(X1, . . . ,Xm) and
Ym = σ(Y1, . . . ,Ym) be the corresponding sigma fields. A response-adaptive
design is defined by
ψm = E(Xm|Xm−1,Ym−1).
Now, assume that covariate information is available in the clinical study.
Let ξm be the covariate of the m-th subject and Zm = σ(ξ1, . . . , ξm) be
the corresponding sigma field. In addition, let Fm = σ(Xm,Ym,Zm) be the
sigma field of the history. A general covariate-adjusted response-adaptive
(CARA) design is defined by
ψm = E(Xm|Fm−1, ξm) = E(Xm|Xm−1,Ym−1,Zm),
the conditional probabilities of assigning treatments 1, ...,K to the mth pa-
tient, conditioning on the entire history including the information of all
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previous m − 1 assignments, responses, and covariate vectors, plus the in-
formation of the current patient’s covariate vector.
A number of attempts have been made to formulate adaptive designs
in the presence of covariates. For example, Zelen (1974) and Pocock and
Simon (1975) considered balancing covariates by using the idea of the biased
coin design (Efron, 1971). Atkinson (1982, 1999, 2002) tackled this problem
by employing the D-optimality criterion with a linear model. The prime
concern of these works is to balance allocations over the covariates with
treatment assignment probabilities
ψm = E(Xm|Xm−1,Zm)
which differs from the CARA designs. These allocation schemes do not
depend on the outcome of the treatment which is important for adaptive
designs that aim to reduce the number of patients that receive the inferior
treatment.
The history to incorporate covariates in response-adaptive designs is
short. For the randomized play-the-winner rule, Bandyopadhyay and Biswas
(1999) incorporated ploytomous covariates with binary responses. Rosen-
berger, Vidyashankar and Agarwal (2001) considered a CARA design for
binary responses that use a logistic regression model. Their encouraging
simulation study indicates that their approach, together with the inclusion
of the covariates, significantly reduces the percentage of treatment failures.
However, theoretical justifications and asymptotic properties have not been
given. Further, the applications of their procedure are limited to two treat-
ments with binary responses.
To compare two treatments, Bandyopadhyay and Biswas (2001) con-
sidered a linear model to utilize covariate information with continuous re-
sponses. A limiting allocation proportion was also derived in their design.
However, according to their proposed scheme, the conditional assignment
probabilities are
ψm = E(Xm|Fm−1).
The above probabilities do not incorporate the covariates of the incoming
patient, which in some cases are crucial. For instance, let the covariate
be gender and there are two treatments, and we assume that male and fe-
male patients react very differently to treatments A and B. Whether the
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next patient is male or female should therefore be considered as an impor-
tant element that affects the assignment of treatment. Recently, Atkinson
(2004) considered adaptive biased-coin designs for K-treatment based on a
linear regression model. Atkinson and Biswas (2005a and 2005b) proposed
adaptive biased-coin designs and Bayesian adaptive biased-coin designs for
clinical trials with normal responses. However, none of these articles pro-
vided asymptotic distribution of the estimators and allocation proportion.
Without the asymptotic properties of the estimators, it is difficult to assess
the validity of the statistical inferences after using CARA designs.
Instead of working on specific setups, we seek to derive a general frame-
work of CARA designs and provide theoretical foundation for using CARA
design. In a CARA design, the assignment of treatment Xm depends on
Fm−1 and the covariate information (ξm) of the incoming patient. This
generates a certain level of technical complexity. However, it is important
to provide a solid foundation (including asymptotic normality) for CARA
designs that can be usefully applied in many circumstances.
1.2. Main results and organization of the paper. The main objectives
are (i) to propose a general CARA design that can be applied to cases in
which K-treatments (K ≥ 2) are present and to different types of responses
(discrete or continuous), and (ii) to study important asymptotic properties
of the CARA design. These properties provide a solid foundation for both
the CARA design and the statistical inference after using a CARA design.
Major mathematical techniques, including martingale theory and Gaussian
approximation, are employed to develop the asymptotic results.
The rest of the paper is organized as follows. In Section 2, we intro-
duce the general framework of the CARA design. Useful asymptotic results
(including the strong consistency and asymptotic normality) of both the
estimators of the unknown parameters and the allocation proportions are
derived. The generalized linear model represents a broad class of applica-
tions and is an important tool in the analysis of data that involve covariates.
In Section 3, the CARA design is applied to generalized linear models, and
two important special cases, the linear model and the logistic regression
model, are considered in detail. Under the general framework, we are able
to propose many new and useful CARA designs. We then conclude our pa-
per with some observations in Section 4. Technical proofs are provided in
the Appendix.
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2. General CARA design.
2.1. General framework. Based on the notation in Section 1, supposing
that a patient with a covariate vector ξ is assigned to treatment k, k =
1, . . . ,K, and the observed response is Yk. Assume that the responses and
the covariate vector satisfy
E[Yk|ξ] = pk(θk, ξ), θk ∈ Θk, k = 1, . . . ,K,
where pk(·, ·), k = 1, . . . ,K, are known functions. Further, θk, k = 1, . . . ,K,
are unknown parameters, and Θk ⊂ Rd is the parameter space of θk. Write
θ = (θ1, . . . ,θK) and Θ = Θ1 × · · · ×ΘK . This model is quite general, and
includes the generalized linear models of McCullagh and Nelder (1989) as
special cases. The discussion of the generalized linear models is undertaken
in Section 3. We assume that {(Ym,1, . . . , Ym,K , ξm), m = 1, 2, . . .} is a
sequence of i.i.d. random vectors, the distributions of which are the same
as that of (Y1, . . . , YK , ξ).
2.2. CARA design. The allocation scheme is as follows. To start,
assign m0 subjects to each treatment by using a restricted randomiza-
tion. Assume that m (m ≥ Km0) subjects have been assigned to treat-
ments. Their responses {Yj , j = 1, . . . ,m} and the corresponding covariates
{ξj , j = 1, . . . ,m} are observed. We let θ̂m = (θ̂m,1, . . . , θ̂m,K) be an esti-
mate of θ = (θ1, . . . ,θK). Here, for each k = 1, . . . ,K, θ̂m,k = θ̂m,k(Yj,k, ξj :
Xj,k = 1, j = 1, . . . ,m) is the estimator of θk that is based on the observed
Nm,k-size sample {(Yj,k, ξj) : for which Xj,k = 1, j = 1 . . . ,m}. Next, when
the (m + 1)-th subject is ready for randomization and the corresponding
covariate ξm+1 is recorded, we assign the patient to treatment k with a
probability of
ψk = P
(
Xm+1,k = 1
∣∣Fm, ξm+1) = pik(θ̂m, ξm+1) k = 1, . . . ,K, (2.1)
where Fm = σ(X1, . . . ,Xm,Y1, . . . ,Ym, ξ1, . . . , ξm) is the sigma field of
the history and pik(·, ·), k = 1, ...,K are some given functions. Given
Fm and ξm+1, the response Ym+1 of the (m + 1)-th subject is assumed
to be independent of its assignment Xm+1. We call the function pi(·, ·) =(
pi1(·, ·), . . . , piK(·, ·)
)
the allocation function that satisfies pi1+ · · ·+piK ≡ 1.
Let gk(θ
∗) = E[pik(θ
∗, ξ)]. From (2.1), it follows that
P
(
Xm+1,k = 1
∣∣Fm) = gk(θ̂m), k = 1, . . . ,K. (2.2)
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Different choices of pi(·, ·) generate different possible classes of useful
designs. For example, we can take pik(θ, ξ) = Rk(θ1ξ
T , . . . ,θKξ
T ), k =
1, . . . ,K, which includes a large class of applications. Here, 0 < Rk(z) < 1,
k = 1, . . . ,K, are real functions that are defined in RK with
K∑
k=1
Rk(z) = 1 and Ri(z) = Rj(z) whenever zi = zj . (2.3)
For simplicity, it is assumed that ξ and θk, k = 1, . . . ,K have the same
dimensions, otherwise, slight modifications are necessary (see Example 3.1
for an illustration). In practice, the functions Rk can be defined as
Rk(z) =
G(zk)
G(z1) + · · ·+G(zK) , k = 1, . . . ,K,
where G is a smooth real function that is defined in R and satisfies 0 <
G(z) < ∞. An example is that Rk(z) = eTzk/(eTz1 + · · · + eTzK ), k =
1, . . . ,K.
In the two-treatment case, we can let R1(z1, z2) = G(z1 − z2) and
R2(z1, z2) = G(z2 − z1), where G is real function defined on R satisfying
G(0) = 1/2, G(−z) = 1−G(z) and 0 < G(z) < 1 for all z. For the logistic
regression model, Rosenberger, Vidyashankar and Agarwal (2001) suggested
using the estimated covariate-adjusted odds ratio to allocate subjects, which
is equivalent to defining Rk(z1, z2) = e
zk/(ez1 +ez2), k = 1, 2. For each fixed
covariate ξ, we can also choose pi(θ, ξ) according to Baldi Antognini and
Giovagnoli (2004) and Hu and Rosenberger (2003). When pi(θ, ξ) does not
depend on ξ, one can use the allocation scheme of Bandyopadhyay and
Biswas (2001) for the normal linear regression model. We now introduce
some important asymptotic properties.
2.3. Asymptotic properties. Write pi(θ∗,x) =
(
pi1(θ
∗,x), . . . , piK(θ
∗,x)
)
,
g(θ∗) =
(
g1(θ
∗), . . . , gK(θ
∗)
)
, vk = gk(θ) = E[pik(θ, ξ)], k = 1, . . . ,K, and
v = (v1, . . . , vK). We assume that 0 < vk < 1, k = 1, . . . ,K. For the
allocation function pi(θ∗,x) we assume the following condition.
Condition A We assume that the parameter space Θk is a bounded domain
in Rd, and that the true value θk is an interior point of Θk, k = 1, . . . ,K.
1. For each fixed x, pik(θ
∗,x) > 0 is a continuous function of θ∗, k =
1, . . . ,K.
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2. For each k = 1, . . . ,K, pik(θ
∗, ξ) is differentiable with respect to θ∗
under the expectation, and there is a δ > 0 such that
gk(θ
∗) = gk(θ) + (θ
∗ − θ)(∂gk
∂θ∗
∣∣∣
θ
)T
+ o(‖θ∗ − θ‖1+δ),
where ∂gk/∂θ
∗ = (∂g/∂θ∗11, . . . , ∂g/∂θ
∗
Kd).
Theorem 2.1 Suppose that for k = 1, . . . ,K,
θ̂nk − θk = 1
n
n∑
m=1
Xm,khk(Ym,k, ξm)
(
1 + o(1)
)
+ o(n−1/2) a.s., (2.4)
where hk are K functions with E[hk(Yk, ξ)|ξ] = 0. We also assume that
E‖hk(Yk, ξ)‖2 < ∞, k = 1, . . . ,K. Then under Condition A, we have for
k = 1, . . . ,K,
P
(
Xn,k = 1
)→ vk; P(Xn,k = 1|Fn−1, ξn = x)→ pik(θ,x) a.s. (2.5)
and
Nn
n
− v = O
(√ log log n
n
)
a.s.; θ̂n − θ = O
(√ log log n
n
)
. (2.6)
Further, let Vk = E{pik(θ, ξ)(hk(Yk, ξ))Thk(Yk, ξ)}, k = 1, . . . ,K,
V = diag
(
V1, . . . ,VK
)
, Σ1 = diag(v)−vT v, Σ2 =
∑K
k=1
∂g
∂θk
Vk
( ∂g
∂θk
)T
and
Σ = Σ1 + 2Σ2. Then,
√
n(Nn/n− v) D→ N(0,Σ) and
√
n(θ̂n − θ) D→ N(0,V ). (2.7)
Remark 2.1 Condition (2.4) depends on different estimation methods. In
the next section, we show that it is satisfied in many cases.
Theorem 2.1 provides general results on the asymptotic properties of
the allocation proportions Nn,k/n, k = 1, . . . ,K. Sometimes, one may be
interested in the proportions for a given covariate (for discrete ξ) as discussed
in Section 3. Given a covariate x, the proportion of subjects that is assigned
to treatment k is ∑n
m=1Xm,kI{ξm = x}∑n
m=1 I{ξm = x}
:=
Nn,k|x
Nn(x)
,
whereNn,k|x is the number of subjects with covariate x that is randomized to
treatment k, k = 1, . . . ,K, in the n trials, and Nn(x) is the total number of
subjects with covariate x. WriteNn|x = (Nn,1|x, . . . , Nn,K|x). The following
theorem establishes the asymptotic results of these proportions.
7
Theorem 2.2 Given a covariate x, suppose that P
(
ξ = x
)
> 0. Under
Condition A and (2.4), we have
Nn,k|x/Nn(x)→ pik(θ,x) a.s. k = 1, . . . ,K (2.8)
and √
Nn(x)
(
Nn|x/Nn(x)− pi(θ,x)
) D→ N(0,Σ|x), (2.9)
where
Σ|x = diag(pi(θ,x))−pi(θ,x)T pi(θ,x)+2
K∑
k=1
∂pi(θ,x)
∂θk
Vk
(∂pi(θ,x)
∂θk
)T
P(ξ = x).
3. Generalized linear models.
In this section, the general results of Section 2 are applied to the gener-
alized linear model (GLM) and its two special cases, the logistic regression
model and the linear model (refer to McCullagh and Nelder (1989) for ap-
plications of these models). Suppose, given ξ, that the response Yk of a trial
of treatment k has a distribution in the exponential family, and takes the
form
fk(yk|ξ,θk) = exp
{
(ykµk − ak(µk))/φk + bk(yk, φk)} (3.1)
with link function µk = hk(ξθ
T
k ), where θk = (θk1, . . . , θkd), k = 1, . . . ,K,
are coefficients. Assume that the scale parameter φk is fixed, then E[Yk|ξ] =
a′k(µk), Var(Yk|ξ) = a′′k(µk)φk and
∂ log fk(yk|ξ,θk)
∂θk
=
1
φk
{yk − a′k(µk)}h′k(ξθTk )ξ,
∂2 log fk(yk|ξ,θk)
∂θ2k
=
1
φk
{
− a′′k(µk)[h′k(ξθTk )]2 + [yk − a′k(µk)]h′′k(ξθTk )
}
ξT ξ.
Thus, given ξ, the conditional Fisher information matrix is
Ik(θk|ξ) = −E
[∂2 log fk(Yk|ξ,θk)
∂θ2k
∣∣∣ξ] = 1
φk
a′′k(µk)[h
′
k(ξθ
T
k )]
2ξT ξ.
For the observations up to stage m, the likelihood function is
L(θ) =
m∏
j=1
K∏
k=1
[fk(Yj,k|ξj ,θk)]Xj,k =
K∏
k=1
m∏
j=1
[fk(Yj,k|ξj ,θk)]Xj,k :=
K∏
k=1
Lk(θk)
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with logLk(θk) ∝
∑m
j=1Xj,k{Yj,k − ak(µj,k)}, µj,k = hk(θTk ξj), k =
1, 2, . . . ,K. The MLE θ̂m = (θ̂m,1, . . . , θ̂m,K) of θ = (θ1, . . . , θK) is that
for which θ̂m maximizes L(θ) over θ ∈ Θ1 × · · · ×ΘK . Equivalently, θ̂m,k
maximizes Lk over θk ∈ Θk, k = 1, 2, . . . ,K. Rosenberger, Flournoy and
Durham (1997) established a general result for the asymptotic normality of
MLEs from a response-driven design. Rosenberger and Hu (2002) gave the
asymptotic normality of the regression parameters from a generalized linear
model that followed a sequential design with covariate vectors. These two
papers neither examined the case of using covariates to adjust the design,
nor established the asymptotic properties of the allocation proportions. The
next corollary gives results on both the estimators of the parameters and
the allocation proportions.
Corollary 3.1 Define
Ik = Ik(θ) = E{pik(θ, ξ)Ik(θk|ξ)}, k = 1, . . . ,K. (3.2)
Under Condition A, if the matrices Ik, k = 1, 2 . . . ,K, are nonsingular
and the MLE θ̂m is unique, then under regularity condition (A.13) in the
Appendix, we have (2.5), (2.6), and (2.7) with Vk = I
−1
k , k = 1, . . . ,K.
Moreover, if P(ξ = x) > 0 for a given covariate x, then (2.8) and (2.9)
hold.
This result is a corollary of Theorems 2.1 and 2.2. The proof is given in the
Appendix through the verification of Condition (2.4). For both the logistic
regression and the linear regression, condition (A.13) is satisfied.
Remark 3.1 From Theorem 3.1, it follows that√
Nn,k (θ̂n,k − θk) D→ N
(
0, vk{E[pik(θ, ξ)Ik(θk|ξ)]}−1
)
, k = 1, . . . ,K.(3.3)
It should be noted that the asymptotic variances are different from those of
general linear models with a fixed allocation procedure. For the latter, we
have √
Nn,k (θ̂n,k − θk) D→ N
(
0, {E[Ik(θk|ξ)]}−1
)
, k = 1, . . . ,K. (3.4)
If the allocation functions pik(θ, ξ) do not depend on ξ, then pik(θ, ξ) =
gk(θ) = vk, and so (3.3) and (3.4) are identical. Our asymptotic variance-
covariance matrix of θ̂n is also different from that in Theorem 2 of Baldi
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Antognini and Giovagnoli (2004), because the allocation probabilities in their
study do not depend on the covariates.
Remark 3.2 When the distribution of ξ and the true value of θ are known,
the values of v = E[pi(θ, ξ)], ∂g/∂θk = E[∂pi(θ, ξ)/∂θk ] and Ik in (3.2)
can be obtained by computing the expectations, and then the values of the
asymptotic variance-covariance matrices V , Σ and Σ|x can be obtained. In
practice, we can obtain the estimates as follows.
(a) Estimate Ik by În,k =
1
n
∑n
m=1Xm,kIk(θ̂n,k|ξm), k = 1, 2, . . . ,K;
and then the estimator of V is V̂n = diag
(
Î−1n,1, . . . , Î
−1
n,K
)
.
(b) Estimate Σ1 and
∂g
∂θk
, respectively, by
Σ̂1 = diag(
Nn
n
)− (Nn
n
)TNn
n
and
∂̂g
∂θk
=
1
n
n∑
m=1
∂pi(θ∗, ξm)
∂θ∗k
∣∣
θ∗=θ̂n
.
(c) Define the estimator Σ̂ of Σ by Σ̂ = Σ̂1 + 2
∑K
k=1
∂̂g
∂θk
V̂n,k
( ∂̂g
∂θk
)T
.
(d) For a given covariate x, we can estimate Σ|x by
Σ̂|x = diag(pi(θ̂n,x))− pi(θ̂n,x)Tpi(θ̂n,x)
+2
∑K
k=1
(
∂pi(θ∗ ,x)
∂θ∗
k
∣∣∣
θ∗=θ̂n
)
V̂n,k
(
∂pi(θ∗ ,x)
∂θ∗
k
∣∣∣
θ∗=θ̂n
)T #{m≤n:ξm=x}
n .
Notice that φkIk(θ|ξ) does not depend on φk. When φk is unknown, we can
estimate Ik in the same way after replacing φk with its estimate φ̂k.
We now consider two examples, the logistic regression model and the
linear model.
Example 3.1. Logistic Regression Model. We consider the case of
dichotomous (i.e., success or failure) responses. Let Yk = 1 if a subject
being given treatment k is a success and 0 otherwise, k = 1, . . . ,K. Let
pk = pk(θk, ξ) = P(Yk = 1|ξ) be the probability of the success of a trial of
treatment k for a given covariate ξ, qk = 1− pk, k = 1, . . . ,K. Assume that
logit(pk) = αk + θkξ
T , k = 1, . . . ,K. (3.5)
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Without loss of generality, we assume that αk = 0, k = 1, 2, . . . ,K, or
alternatively, we can redefine the covariate vector to be (1, ξ). For each
k = 1, . . . ,K, let pj,k = pk(θk, ξk). With the observations up to stage m,
the MLE θ̂m,k of θk (k = 1, . . . ,K) is that for which θ̂m,k maximizes
Lk =:
m∏
j=1
p
Xj,kYj,k
j,k (1− pj,k)Xj,k(1−Yj,k) over θk ∈ Θk. (3.6)
The logistic regression model is a special case of GLM (3.1) with φk = 1,
µk = log(pk/qk), hk(x) = x, bk(yk, φk) = 0, and ak(µk) = − log(1 − pk) =
log(1+eµk ). Thus, given ξ, the conditional information matrix is Ik(θk|ξ) =
a′′k(µk)ξ
T ξ = pkqkξ
T ξ. For Theorem 3.1, we have the following corollary.
Corollary 3.2 Suppose that Condition A is satisfied, E‖ξ‖2 < ∞, and the
matrix E[ξT ξ] is nonsingular. We then have (2.5), (2.6), (2.7) with Vk =
I−1k and Ik = E{pik(θ, ξ)pkqkξT ξ}, k = 1, . . . ,K.Moreover, if P(ξ = x) > 0
for a given covariate x, then (2.8) and (2.9) hold.
Example 3.2. Normal Linear Regression Model. The responses are nor-
mally distributed, that is, Yk|ξ ∼ N(µk, σ2k) with link function µk = θkξT ,
then the linear model is a special case of GLM (3.1) with φk = σ
2
k, ak(µk) =
µ2k/2 and hk(x) = x. Thus, we have the following corollary.
Corollary 3.3 Suppose that the conditions in Corollary 3.2 are satisfied.
We then have (2.5), (2.6), (2.7) with Vk = I
−1
k and Ik = E[pik(θ, ξ)ξ
T ξ]/σ2k,
k = 1, . . . ,K. Moreover, if P(ξ = x) > 0 for given x, then (2.8) and (2.9)
hold.
Remark 3.3 Bandyopadhyay and Biswas (2001) considered the normal lin-
ear regression model in which θ11 = µ1, θ21 = µ2, θ1j = θ2j = βj−1,
j = 2, . . . , d, and the first component of ξ is 1. Their proposed allocation
probabilities are functions of estimates of the unknown parameters that de-
pend only on information of the previous patients, but not on the covariates
of the incoming patient. Theorem 1 of Bandyopadhyay and Biswas (2001)
gives the consistency property of Nn,1/n and P(Xn,1 = 1). However, their
proof is not correct, since the assignments δ1, · · · , δi are functions of the
previous responses Y1, · · · , Yi−1 and covariates. In fact, given the assign-
ments δ1, · · · , δi, the responses Y1, · · · , Yi are no longer independent normal
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variables, which implies that their equation (4) is not valid. Nevertheless, if
we let
ξ = (1, ξ˜), a = Eξ˜, I
ξ˜
= Var{ξ˜}, v1 = Φ(µ1 − µ2
T
) and v2 = 1− v1,
under our theoretical framework, it can be proved that Theorem 1 of Bandy-
opadhyay and Biswas (2001) is correct. Further, it is not difficult to show
that
√
n(µ̂n1−µ1, µ̂n2−µ2) D→ N
(
(0, 0), σ2
(
1/v1 + aI
−1
ξ˜
aT aI−1
ξ˜
aT
aI−1
ξ˜
aT 1/v2 + aI
−1
ξ˜
aT
))
,
√
n(β̂n − β) D→ N(0, σ2I−1
ξ˜
),
and
√
n (Nn1/n− v1) D→ N
(
0, v1v2 +
2σ2
v1v2
(
Φ′(
µ1 − µ2
T
)
)2)
,
where σ2 is the variance of the errors in the linear model.
Remark 3.4 Corollary 3.3 can be generalized to general responses. Suppose
that the response Yk of a subject to treatment k, k = 1, . . . ,K, and its
covariate ξ satisfies the linear regression model
E[Yk|ξ] = pk(θk, ξ) = θkξT , k = 1, . . . ,K.
For the observations up to stage m, let θ̂m,k minimize the error sum of
squares
Sk(θk) =
m∑
j=1
Xj,k(Yj,k − θkξTj )2 over θk ∈ Θk,
k = 1, . . . ,K. Here, θ̂m,k is the least-squares estimator (LSE) of θk. Then
Corollary 3.3 remains true with Vk = I
−1
ξk IY kI
−1
ξk , Iξk = E[pik(θ, ξ)ξ
T ξ]
and IY k = E{pik(θ, ξ)(Yk − θkξT )2ξT ξ} under the condition E‖Ykξ‖2 < ∞,
k = 1, . . . ,K. This result follows from Theorem 2.1, as condition (2.4) is
satisfied with hk = (Yk − θkξT )ξI−1ξk .
4. Discussion.
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This paper makes two major contributions. First, a comprehensive
framework of CARA designs is proposed to serve as a paradigm for treat-
ment allocation procedures in clinical trials when covariates are available. It
is a very general framework that allows a wide spectrum of applications to
very general statistical models, including generalized linear models as special
cases. Second, asymptotic properties are obtained to provide a statistical
basis for inferences after using a CARA design.
When covariate information is not being used in the treatment allocation
scheme, an optimal allocation proportion is usually determined with the as-
sistance of some optimality criteria. Jennison and Turnbull (2000) described
a general procedure to search for an optimal allocation. For CARA designs,
the means to define and obtain an optimal allocation scheme is still unclear.
For CARA design, we can find optimal allocation for each fixed value of the
covariate. Theorem 2.2 provides theoretical support for targeting optimal
allocation by using CARA design for each fixed covariate.
For response-adaptive designs without covariates, Hu and Rosenberger
(2003) studied the relationship among the power, the target allocation, and
the variability of the designs. It is important to study the behavior of the
power function when a CARA design is used in clinical trials. It is not
difficult to derive the power function for binary responses with discrete co-
variates. For the general covariate ξ, the formulation becomes very different,
and it is an interesting topic for future research.
APPENDIX: PROOFS
The proofs of the theorems are organized as follows. First, we prove the
theorems for the general CARA design in Section 2. We then derive the
results in Section 3 by the application of the theorems in Section 2.
Proof of Theorem 2.1. First, notice that for each k = 1, . . . ,K, Xm+1,k =
Xm+1,k − E[Xm+1,k|Fm] + gk(θ̂m) and then
Nn,k = E[X1,k|F0] +
n∑
m=1
(Xm,k − E[Xm,k|Fm−1]) +
n−1∑
m=1
gk(θ̂m). (A.1)
The second term is a martingale. We then show that the third term can be
approximated by another martingale. Write ∆Mm,k = Xm,k−E[Xm,k|Fm−1],
∆Tm,k = Xm,khk(Ym,k, ξm), k = 1, . . . ,K. Let Mn =
∑n
m=1∆Mm and
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Tn =
∑n
m=1∆Tm, where ∆Mm = (∆Mm,1, · · · , ∆Mm,K) and ∆Tm =
(∆Tm,1, · · · ,∆Tm,K). Here, the symbol ∆ denotes the differencing operand
of a sequence {zn}, i.e., ∆zn = zn − zn−1. Then {(Mn,Tn)} is a multi-
dimensional martingale sequence that satisfies
|∆Mn,k| ≤ 1, ‖∆Tn,k‖ ≤ ‖hk(Yn,k, ξn)‖ (A.2)
and E‖hk(Yn,k, ξn)‖2 <∞, k = 1, . . . ,K. It follows that
‖Mn‖ = O(
√
n) and ‖Tn‖ = O(
√
n) in L2. (A.3)
Also, according to the law of the iterated logarithm for martingales, we have
Mn = O
(√
n log log n
)
a.s. and Tn = O
(√
n log log n
)
a.s.. (A.4)
From (A.4) and (2.4), it follows that
θ̂n − θ = O
(√ log log n
n
)
a.s. (A.5)
From (A.1), (A.5), (A.3), and Condition A, it follows that
Nn,k − nvk = Mn,k +
n−1∑
m=1
K∑
j=1
(θ̂m,j − θj)
(∂gk
∂θj
)T
+
n−1∑
m=1
o(‖θ̂m − θ‖1+δ)
= Mn,k +
n∑
m=1
K∑
j=1
Tm,j
(
1 + o(1)
)
m
(∂gk
∂θj
)T
+ o(n1/2) a.s..
= Mn,k +
n∑
m=1
K∑
j=1
Tm,j
m
(∂gk
∂θj
)T
+ o(n1/2) in probability,
that is,
Nn − nv = Mn +
n∑
m=1
K∑
j=1
Tm,j
(
1 + o(1)
)
m
( ∂g
∂θj
)T
+ o(n1/2) a.s.(A.6)
= Gn + o(n
1/2) in probability, (A.7)
where
Gn =Mn +
n∑
m=1
K∑
j=1
Tm,j
m
( ∂g
∂θj
)T
=Mn +
n∑
m=1
K∑
j=1
∆Tm,j
( ∂g
∂θj
)T n∑
i=m
1
i
.
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The combination of (A.4) and (A.6) yields
Nn−nv = O
(√
n log log n
)
+
n∑
m=1
K∑
j=1
O(
√
m log logm)
m
= O
(√
n log log n
)
a.s.
(2.5) is obvious by noting (A.5) and the continuity of pi(·, ξ). The proof of
consistency is thus obtained. Next, we consider the asymptotic normality.
Notice thatMn, Tn, and Gn are all the sum of martingale differences. It is
easy to verify that the Lindberg condition is satisfied by (A.2). To complete
the proof it suffices to derive the variances. First, the conditional variance-
covariance matrices of the martingale difference {∆Mn,∆Tn} satisfy
E[(∆Mn)
T∆Mn|Fn−1] = diag
(
g(θ̂n−1)
)−(g(θ̂n−1))Tg(θ̂n−1)→ Σ1 in L1;
E[(∆Tn,k)
T∆Tn,k|Fn−1] = E
[
pik(x, ξ)
(
hk(Yk, ξ)
)T
hk(Yk, ξ)
]∣∣
x=θ̂n−1
→ Vk in L1;
E[(∆Mn,i)
T∆Tn,j|Fn−1] = 0 for all i, j and E[(∆Tn,i)T∆Tn,j|Fn−1] = 0
for all i 6= j. It follows that Var{Tn}/n→ V and
Var{Gn} =
n∑
m=1
[Σ1 + o(1)] +
n∑
m=1
n∑
l=1
K∑
j=1
l ∧m
ml
∂g
∂θj
[Vj + o(1)]
( ∂g
∂θj
)T
= n(Σ1 + 2Σ2) + o(n) = nΣ+ o(n).
By the central limit theorem for martingales (Hall and Heyde, 1980), it
follows that
√
n(θ̂n − θ) = n−1/2Tn + o(1) D→ N(0,V ) and
√
n(Nn/n − v) = n−1/2Gn + o(1) D→ N(0,Σ). (A.8)
The proof is now complete. 
Proof of Theorem 2.2. First, according to the law of large numbers, we
have
1
n
n∑
m=1
I{ξm = x} → P(ξ = x) a.s. (A.9)
and
1
n
n∑
m=1
Xm,kI{ξm = x} = 1
n
n∑
m=1
(
Xm,kI{ξm = x} − E[Xm,kI{ξm = x}|Fm−1]
)
+
1
n
n∑
m=1
pik(θ̂m−1,x)P(ξm = x)→ pik(θ,x)P(ξ = x) a.s.,
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and thus (2.8) is proved. We then consider the asymptotic normality. The
proof is similar to that of (A.8). The difference lies in the approxima-
tion of the process by a new 2K dimensional martingale and the calcu-
lation of its variance-covariance matrix. Define ζn,k(x) :=
∑n
m=1(Xm,k −
pik(θ,x))I{ξm = x}. Then,√
Nn(x)
( Nn|x
Nn(x)
− pi(θ,x)
)
=
√
n
Nn(x)
ζn,k(x)√
n
, k = 1, . . . ,K.
Notice (A.9). It is sufficient to prove
n−1/2
(
ζn,1(x), . . . , ζn,K(x)
) D→ N(0,Σ|xP(ξ = x)). (A.10)
With the same argument as is used to derive (A.6), we can obtain
ζn,k(x) =
n∑
m=1
(
∆ζn,k(x)− E[∆ζn,k(x)|Fn−1]
)
+
n∑
m=1
(
pik(θ̂m−1,x)− pik(θ,x)
)
P(ξ = x)
=
n∑
m=1
(
∆ζm,k(x)− E[∆ζm,k(x)|Fm−1]
)
+
K∑
j=1
n∑
m=1
Tm,j
m
(∂pik(θ,x)
∂θj
)T
P(ξ = x) + o(n1/2) in probability.
= : Gn,k(x) + o(n
1/2).
Similar to the proof of (A.8), to complete the proof it suffices to get the
variance of Gn(x) = (Gn,1(x), . . . , Gn,K(x)). Let ∆Mn,k(x) = ∆ζn,k(x) −
E[∆ζn,k(x)|Fn−1]. The variance-covariance matrix of the martingale differ-
ence {(∆Mn(x),∆Tn)} then satisfies E[(∆Mn,k(x))2|Fn−1]→ pik(θ,x)
(
1−
pik(θ,x)
)
P(ξ = x),
E[∆Mn,k(x)∆Mn,j(x)|Fn−1]→ −pik(θ,x)pij(θ,x)P(ξ = x) ∀k 6= j, and
E[∆Mn,k(x)∆Tn,j|Fn−1] = 0 ∀i, j in L1. It follows that
Var{Gn(x)} = n
[
diag(pi(θ,x) − pi(θ,x)Tpi(θ,x)P(ξ = x) + o(1)]
+
n∑
m=1
n∑
l=1
K∑
j=1
l ∧m
lm
∂pi(θ,x)
∂θj
[Vj + o(1)]
(∂pi(θ,x)
∂θj
)T
P
2(ξ = x)
= nΣ|xP(ξ = x) + o(n).
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(A.10) is then proved. 
Proof of Corollary 3.1. By Theorem 2.1, it suffices to verify the con-
dition (2.4). Notice that θ̂m,k is a solution to ∂ logLk/∂θk = 0. The appli-
cation of Taylor’s theorem yields
∂ logLk
∂θk
∣∣∣
θk
+ (θ̂m,k − θk)
{∂2 logLk
∂θ2k
∣∣∣
θk
+
∫ 1
0
[ ∂2 logLk
∂θ2k
∣∣∣∣θk+t(θ̂m,k−θk)
θk
]
dt
}
=
∂ logLk
∂θk
∣∣∣
θ̂m,k
= 0,(A.11)
where f(x)
∣∣∣b
a
= f(b)− f(a). Notice that
∂ logLk
∂θk
=
m∑
j=1
Xj,k
∂ log fk(Yj,k|ξj ,θk)
∂θk
(A.12)
and
∂2 logLk
∂θ2k
=
m∑
j=1
Xj,k
∂2 log fk(Yj,k|ξj ,θk)
∂θ2k
.
We assume that the following regular condition
H(δ) =: E
[
sup
‖z‖≤δ
∥∥∥∂2 log fk(Yk|ξ,θk)
∂θ2k
∣∣∣∣θk+z
θk
∥∥∥]→ 0 as δ → 0. (A.13)
This regularity condition is implied by the simple condition that a′′k, h
′′
k are
continuous and ξ is bounded. Under (A.13), one can show that
sup
‖z‖≤δ
∥∥∥ 1
m
∂2 logLk
∂θ2k
∣∣∣∣θk+z
θk
∥∥∥ ≤ H(δ) + o(1) a.s..
However,
m∑
j=1
{
Xj,k
∂2 log fk(Yj,k|ξj ,θk)
∂θ2k
− E
[
Xj,k
∂2 log fk(Yj,k|ξj ,θk)
∂θ2k
∣∣∣Fj−1]}
is a martingale. According to the law of large numbers,
∂2 logLk
∂θ2k
=
m∑
j=1
E
[
Xj,k
∂2 log fk(Yj,k|ξj ,θk)
∂θ2k
∣∣∣Fj−1]+ o(m)
= −
m∑
j=1
{
E
[
pik(z, ξ)Ik(θk|ξ)
]}
z=θ̂j−1
+ o(m) = −mIk + o(m) a.s.(A.14)
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The substitution of (A.12) and (A.14) into (A.11) yields
m(θ̂m,k − θk)
{
Ik + o(1) +O
(
H(‖θ̂m,k − θk‖)
)}
=
m∑
j=1
Xj,k
∂ log fk(Yj,k|ξj ,θk)
∂θk
.
Thus,
θ̂m,k − θk = 1
m
m∑
j=1
Xj,k
∂ log fk(Yj,k|ξj ,θk)
∂θk
I−1k
(
1 + o(1)
)
a.s.(A.15)
Notice that
E[
∂ log fk(Yj,k|ξj ,θk)
∂θk
|ξj ] = 0 and Var
{∂ log fk(Yj,k|ξj ,θk)
∂θk
|ξj
}
= Ik(θk|ξj).
Hence, Condition (2.4) is valid. By Theorem 2.1, the proof is complete. 
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APPENDIX B: Additional PROOFS
Proof of the existence and consistency of the solution of (A.11): It suffices
to show that, for any δ > 0 small enough, with probability one for m large enough we
have
logLk(θ
∗
k) < logLk(θk), if ‖θ∗k − θk‖ = δ. (B.1)
The application of Taylor’s theorem yields
1
m
logLk(θ
∗
k)− 1
m
logLk(θk)
=(θ∗k − θk) 1
m
∂ logLk
∂θk
∣∣∣
θk
+ (θ∗k − θk) 1
m
∂2 logLk
∂θ2k
∣∣∣
θk
(θ∗k − θk)T
+ (θ∗k − θk)
{ 1
m
∫ 1
0
[ ∂2 logLk
∂θ2k
∣∣∣∣θk+t(θ∗k−θk)
θk
]
dt
}
(θ∗k − θk)T .
So with probability one for m large enough,
1
m
logLk(θ
∗
k)− 1m logLk(θk)
≤− (θ∗k − θk)
{ 1
m
m∑
j=1
{
E
[
πk(z, ξ)Ik(θk|ξ)
]}
z=θ̂j−1
}
(θ∗k − θk)T
+ ‖θ∗k − θk‖2H(‖θ∗k − θk‖) + o(1)
≤− ‖θ∗k − θk‖2 min
‖y‖=1,z∈Θk
{
y
{
E
[
πk(z, ξ)Ik(θk|ξ)
]}
y
T
}
+ ‖θ∗k − θk‖2H(‖θ∗k − θk‖) + o(1)
≤− c0δ2 + δ2H(δ) + o(1) < 0 uniformly in θ∗k with ‖θ∗k − θk‖ = δ
when δ is small enough. (B.1) is proved. 
Proof of Corollary 3.2: Notice
∂2 log fk(Yk|ξ, θk)
∂θ2k
= −pkqkξT ξ
is bounded by ‖ξ‖2 and is continuous in θk. It follows that the regularity condition (A.13)
is satisfied due to the domained convergence theorem. On the other hand, it is obviously
that
∂2 logLk
∂θ2
= −
m∑
j=1
Xj,kpk(θk, ξj)qk(θk, ξj)ξ
T
ξ
is a negatively definite matrix, and so logLk(θ
∗
k) is a strictly concave function of θ
∗
k. It
follows that the MLE is unique. Corollary 3.2 now follows from Corollary 3.1. 
Proof of Remark 3.4: It is obviously that Sk(θk) is strictly convex function of θk.
It follows that the LSE θ̂m,k exists and is unique. On the hand, it is easily seen that θ̂m,k
is the solution of the normal equation as
(
θ̂m,k − θk
) 1
m
[
m∑
j=1
Xj,kξ
T
j ξj ] =
1
m
m∑
j=1
Xj,k(Yj,k − θkξTj )ξj . (B.2)
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Also, {Xj,kξTj ξj − E[Xj,kξTj ξj |Fj−1]} and {Xj,k(Yj,k − θkξTj )ξj} are both sequences of
martingale differences. It follows from the law of large numbers for martingales that,
1
m
m∑
j=1
Xj,kξ
T
j ξj =
1
m
m∑
j=1
E[Xj,kξ
T
j ξj |Fj−1] + o(1)
=
1
m
m∑
j=1
(
E[πk(x, ξ)ξ
T
ξ]
)∣∣
x=θ̂j−1
+ o(1) a.s. (B.3)
and
1
m
m∑
j=1
Xj,k(Yj,k − θkξTj )ξj → 0 a.s.
It follows that∥∥θ̂m,k − θk∥∥2{ min
‖y‖=1,x∈Θk
y
(
E[πk(x, ξ)ξ
T
ξ]
)
y
T − o(1)
}
≤(θ̂m,k − θk) 1
m
[
m∑
j=1
Xj,kξ
T
j ξj ]
(
θ̂m,k − θk
)T
=
1
m
m∑
j=1
Xj,k(Yj,k − θkξTj )ξj
(
θ̂m,k − θk
)T
= o(1)
∥∥θ̂m,k − θk∥∥ a.s.
Hence
θ̂m,k → θk a.s. (B.4)
Now, by (B.3) and (B.4),
1
m
m∑
j=1
Xj,kξ
T
j ξj = Iξk + o(1) a.s.,
which, together with (B.2), implies that
θ̂m,k − θk = 1
m
m∑
j=1
Xj,k(Yj,k − θkξTj )ξjI−1ξ,k
(
1 + o(1)
)
a.s.
Notice E[(Yj,k − θkξTj
)
ξj
∣∣ξj ] = 0. (2.4) is satisfied with hk = (Yk − θkξT )ξI−1ξ,k .
Proof of Remark 3.3: Now, the model is
Yj = Xj,1µ1 +Xj,2µ2 + βξ˜
T
j + ǫj .
Let
S(µ∗1, µ
∗
2 ,β
∗) =
m∑
j=1
(Yj −Xj,1µ∗1 −Xj,2µ∗2 − β∗ξ˜Tj )2.
Wirte ηj = (Xj,1, Xj,2, ξ˜) and θ = (µ1, µ2,β). With the same argument of proving
Corollary 3.4, we have that the LSE θ̂m exists and is unique, and further, satisfies the
equation:
(θ̂m − θ)
[
1
m
m∑
j=1
ηTj ηj
]
=
1
m
m∑
j=1
ǫjηj .
21
Write
I(θ) =
 π1(µ1−µ2T ) 0 π1(µ1−µ2T )a0 π2(µ1−µ2T ) π2(µ1−µ2T )a
π1(
µ1−µ2
T
)aT π2(
µ1−µ2
T
)aT Eξ˜T ξ
 .
Notice the assignment probability at stage j depends only on the estimator θ̂j−1 and
does depend on the covariate ξj . It follows that v1 = π1(
µ1−µ2
T
), v2 = π2(
µ1−µ2
T
),
E[ǫjηj
∣∣Fj−1] = 0,
Var[ǫjηj
∣∣Fj−1] = σ2E[ηTj ηj∣∣Fj−1] = σ2I(θ̂j−1)
and
1
m
m∑
j=1
ηTj ηj =
1
m
m∑
j=1
I(θ̂j−1) + o(1).
So, similar to (B.4),
θ̂m → θ a.s.
Further
θ̂m − θ = 1
m
m∑
j=1
ǫjηjI
−1(1 + o(1)) a.s., (B.5)
where I = I(θ) and
I
−1 =
1/v1 + aI
−1
ξ˜
aT aI−1
ξ˜
aT −aI−1
ξ˜
aI−1
ξ˜
aT 1/v2 + aI
−1
ξ˜
aT −aI−1
ξ˜
−I−1
ξ˜
aT −I−1
ξ˜
aT I−1
ξ˜
 .
It follows that
√
m(θ̂m − θ) = 1√
m
m∑
j=1
ǫjηjI
−1 + oP (1)
D→ N(0, I−1).
From (B.5), it follows that
µ̂m1 − µ̂m2 =
(
1
nv1
m∑
j=1
ǫjXj,1 − 1
nv2
m∑
j=1
ǫjXj,2
)
(1 + o(1)) a.s.
The remainder of the proof is similar to that of Theorem 2.1.
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